1. Accuracy of repeated measurements of late‐night salivary cortisol to screen for early‐stage recurrence of Cushing's disease following pituitary surgery. (25th July 2014) Authors: Danet‐Lamasou, Marie; Asselineau, Julien; Perez, Paul; Vivot, Alexandre; Nunes, Marie‐Laure; Loiseau, Hugues; San‐Galli, François; Cherifi‐Gatta, Blandine; Corcuff, Jean‐Benoît; Tabarin, Antoine Journal: Clinical endocrinology Issue: Volume 82:Number 2(2015:Feb.) Page Start: 260 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Availability of results of academic randomized trials involving cooperative groups in oncology in France: A systematic search of clinical trial registries. (September 2022) Authors: Créquit, Perrine; Vivot, Alexandre; Grégory, Jules; Milleron, Bernard Journal: Journal of cancer policy Issue: Volume 33(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Corrigendum to: Rituximab for induction and maintenance therapy of granulomatosis with polyangiitis: a single-centre cohort study on 114 patients. (3rd March 2022) Authors: Puéchal, Xavier; Iudici, Michele; Calich, Ana Luisa; Vivot, Alexandre; Terrier, Benjamin; Régent, Alexis; Cohen, Pascal; Jeunne, Claire Le; Mouthon, Luc; Ravaud, Philippe; Guillevin, Loïc Journal: Rheumatology Issue: Volume 61:Number 8(2022) Page Start: 3505 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Factors Associated With Postmarketing Research for Approved Indications for Novel Medicines Approved by Both the FDA and EMA Between 2005 and 2010: A Multivariable Analysis. Issue 5 (24th February 2018) Authors: Zeitoun, Jean‐David; Ross, Joseph S.; Atal, Ignacio; Vivot, Alexandre; Downing, Nicholas S.; Baron, Gabriel; Ravaud, Philippe Journal: Clinical pharmacology & therapeutics Issue: Volume 104:Issue 5(2018) Page Start: 1000 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Postmarketing studies for novel drugs approved by both the FDA and EMA between 2005 and 2010: a cross-sectional study. Issue 12 (21st December 2017) Authors: Zeitoun, Jean-David; Ross, Joseph S; Atal, Ignacio; Vivot, Alexandre; Downing, Nicholas S; Baron, Gabriel; Ravaud, Philippe Journal: BMJ open Issue: Volume 7:Issue 12(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Post‐marketing research and its outcome for novel anticancer agents approved by both the FDA and EMA between 2005 and 2010: A cross‐sectional study. Issue 2 (12th October 2017) Authors: Zeitoun, Jean‐David; Baron, Gabriel; Vivot, Alexandre; Atal, Ignacio; Downing, Nicholas S; Ross, Joseph S; Ravaud, Philippe Journal: International journal of cancer Issue: Volume 142:Issue 2(2018) Page Start: 414 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Rituximab for induction and maintenance therapy of granulomatosis with polyangiitis: a single-centre cohort study on 114 patients. (2nd May 2018) Authors: Puéchal, Xavier; Iudici, Michele; Calich, Ana Luisa; Vivot, Alexandre; Terrier, Benjamin; Régent, Alexis; Cohen, Pascal; Jeunne, Claire Le; Mouthon, Luc; Ravaud, Philippe; Guillevin, Loïc Journal: Rheumatology Issue: Volume 58:Number 3(2019) Page Start: 401 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Should we consider day-2 and day-3 embryo morphology before day-5 transfer when blastocysts reach a similar good quality?. Issue 5 (November 2017) Authors: Herbemont, Charlene; Sarandi, Solmaz; Boujenah, Jeremy; Cedrin-Durnerin, Isabelle; Sermondade, Nathalie; Vivot, Alexandre; Poncelet, Christophe; Grynberg, Michael; Sifer, Christophe Journal: Reproductive biomedicine online Issue: Volume 35:Issue 5(2017) Page Start: 521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗